BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2323677)

  • 1. Transferrin derivatives with growth factor activities in acute myeloblastic leukemia: an autocrine/paracrine pathway.
    Pflüger KH; Grüber A; Welslau M; Köppler H; Havemann K
    Haematol Blood Transfus; 1990; 33():87-94. PubMed ID: 2323677
    [No Abstract]   [Full Text] [Related]  

  • 2. Maturation inducer activity and the process of human myeloid leukemia cell differentiation.
    Chiao JW
    Blood Cells; 1987; 13(1-2):111-5. PubMed ID: 3311211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cell surface transferrin receptor in the assessment of estradiol stimulating effect on cultured breast cancer cells.
    Vandewalle B; Revillion-Carette F; Lefebvre J
    Anticancer Res; 1988; 8(3):495-8. PubMed ID: 3389752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of a novel autocrine transferrin-like growth factor in acute myeloblastic leukemia.
    Grüber A; Pflüger KH; Schöneberger J; Wenzel E; Havemann K
    Leuk Lymphoma; 1993 Nov; 11(5-6):435-41. PubMed ID: 8124216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.
    Taetle R; Rhyner K; Castagnola J; To D; Mendelsohn J
    J Clin Invest; 1985 Mar; 75(3):1061-7. PubMed ID: 2984253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation.
    Vostrejs M; Moran PL; Seligman PA
    J Clin Invest; 1988 Jul; 82(1):331-9. PubMed ID: 2839550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the proliferative response to granulocyte colony-stimulating factor and the positivity of transferrin receptor in acute myeloblastic leukemia cells.
    Motoji T; Mineshima M; Watanabe M; Takanashi M; Masuda M; Oshimi K; Mizoguchi H
    J Cell Physiol; 1991 Sep; 148(3):421-5. PubMed ID: 1717498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors required for proliferation of clonogenic cells in acute myeloblastic leukemia (AML).
    Griffin JD
    Haematologica; 1987; 72(6 Suppl):85-8. PubMed ID: 3127305
    [No Abstract]   [Full Text] [Related]  

  • 9. A 41 kDa transferrin related molecule acts as an autocrine growth factor for HL-60 cells.
    Dittmann KH; Petrides PE
    Biochem Biophys Res Commun; 1991 Apr; 176(1):473-8. PubMed ID: 2018536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of IL-1 regulated and spontaneous growth of acute myeloid leukemia in vitro.
    Delwel R; Schipper P; van Buitenen C; van Agthoven T; Touw I; Löwenberg B
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():22-6. PubMed ID: 2390638
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity in acute myeloblastic leukemia.
    McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE
    Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to transferrin receptor and assay of their biological effects.
    Trowbridge IS; Lesley JF; Domingo D; Schulte R; Sauvage C; Rammensee HG
    Methods Enzymol; 1987; 147():265-79. PubMed ID: 3670087
    [No Abstract]   [Full Text] [Related]  

  • 13. Conformational change of p53 protein in growth factor-stimulated human myelogenous leukemia cells.
    Zhang W; Deisseroth AB
    Leuk Lymphoma; 1994 Jul; 14(3-4):251-5. PubMed ID: 7950913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor regulation is coupled to intracellular ferritin in proliferating and differentiating HL60 leukemia cells.
    Rhyner K; Taetle R; Bering H; To D
    J Cell Physiol; 1985 Dec; 125(3):608-12. PubMed ID: 2999167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mast cell growth factor on clonogenic blast cell growth in acute myelogenous leukemia.
    Siitonen T; Lundström M; Zheng A; Savolainen ER; Koistinen P
    Ann Hematol; 1996 Aug; 73(2):71-8. PubMed ID: 8774615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.
    Zhu YM; Bradbury DA; Russell NH
    Br J Cancer; 1994 Mar; 69(3):468-72. PubMed ID: 8123475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms.
    Chitambar CR; Zivkovic Z
    Cancer Res; 1987 Aug; 47(15):3929-34. PubMed ID: 3475168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analysis of the human transferrin receptor: effects of anti-receptor monoclonal antibodies on tumor growth.
    Trowbridge IS; Collawn J; Jing S; White S; Esekogwu V; Stangel M
    Curr Stud Hematol Blood Transfus; 1991; (58):139-47. PubMed ID: 1954762
    [No Abstract]   [Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA; Groshek P; Griffin JD
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-9 in human myeloid leukemia cells.
    Lemoli RM; Fortuna A; Tafuri A; Grande A; Amabile M; Martinelli G; Ferrari S; Tura S
    Leuk Lymphoma; 1997 Aug; 26(5-6):563-73. PubMed ID: 9389363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.